CannaGrowth.com | Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray
28686
post-template-default,single,single-post,postid-28686,single-format-standard,ajax_fade,page_not_loaded,,vertical_menu_enabled,side_area_uncovered_from_content,qode-theme-ver-7.2,wpb-js-composer js-comp-ver-4.5.1,vc_responsive

Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray

19 Mar Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray

Toronto-based medical marijuana producer Tilray announced Monday it has formed a strategic partnership with Sandoz Canada, the first known affiliation between a marijuana producer and a major pharmaceutical company. Tilray signed a letter of intent with the Quebec-based affiliate of Sandoz International GmbH, an arm of global health care giant Novartis. The entry of Big […] Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

The post Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray appeared first on InvestinCannabis.com.

No Comments

Sorry, the comment form is closed at this time.